Breaking News Instant updates and real-time market news.

2021-04-04 15:12:45 ABBV AbbVie $108.44 / +0.23 (+0.21%) 15:12 04/04/21 04/04 15:12 04/04/21 15:12	AbbVie announces extension of review of sNDA of upadacitinib AbbVie announced that the U.S. Food and Drug Administration has extended the review period for the supplemental New Drug Application for upadacitinib in the treatment of adults and adolescents with moderate to severe atopic dermatitis. The Prescription Drug User Fee Act action date has been extended three months to early Q3 2021. As previously disclosed, AbbVie received an information request from the FDA for an updated assessment of the benefit-risk profile for upadacitinib in atopic dermatitis. AbbVie responded to the request and the FDA has informed AbbVie that, as expected, it requires additional time for a full review of the submission.	30 Apr 07 May 24 May
ABBV AbbVie $108.44 / +0.23 (+0.21%) 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 04/01/21 Piper Sandler Piper migraine survey bearish for Amgen, bullish for Biohaven 03/17/21 JPMorgan AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho

2021-04-04 15:12:45

ABBV

AbbVie

$108.44 / +0.23 (+0.21%)

15:12

04/04/21

04/04

15:12

04/04/21

15:12

AbbVie announces extension of review of sNDA of upadacitinib

AbbVie announced that the U.S. Food and Drug Administration has extended the review period for the supplemental New Drug Application for upadacitinib in the treatment of adults and adolescents with moderate to severe atopic dermatitis. The Prescription Drug User Fee Act action date has been extended three months to early Q3 2021. As previously disclosed, AbbVie received an information request from the FDA for an updated assessment of the benefit-risk profile for upadacitinib in atopic dermatitis. AbbVie responded to the request and the FDA has informed AbbVie that, as expected, it requires additional time for a full review of the submission.

30
Apr
07
May
24
May

ABBV AbbVie

$108.44 / +0.23 (+0.21%)

04/01/21 Piper Sandler: Integra to benefit from FDA safety communication, says Piper Sandler

04/01/21 Piper Sandler: Piper migraine survey bearish for Amgen, bullish for Biohaven

03/17/21 JPMorgan: AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan

03/17/21 Mizuho: AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho

TODAY'S FREE FLY STORIES

Options	JetBlue call volume above normal and directionally bullish » 11:45 04/13/21 04/13 11:45 04/13/21 11:45 JBLU JetBlue $20.46 / -0.035 (-0.17%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options JBLU JetBlue $20.46 / -0.035 (-0.17%) 10:06 Today JetBlue, Qatar Airways expand strategic codeshare agreement 04/05/21 CDC issues updated guidance on travel for fully vaccinated people 03/25/21 JetBlue announces launch of Paisly by JetBlue, a new travel website 03/17/21 JetBlue, CommonPass launch digital health pass for Boston to Aruba travelers JBLU JetBlue $20.46 / -0.035 (-0.17%) 09:55 Today Fly Intel: Top five analyst upgrades 07:01 Today Susquehanna JetBlue upgraded to Positive at Susquehanna 05:55 Today Susquehanna JetBlue upgraded to Positive from Neutral at Susquehanna 04/06/21 Morgan Stanley JetBlue price target raised to $30 from $18 at Morgan Stanley JBLU JetBlue $20.46 / -0.035 (-0.17%) 01/28/21 JetBlue reports Q4 EPS ($1.53) consensus ($1.69) 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/27/20 JetBlue reports Q3 adj. EPS ($1.75), consensus ($2.00) 02 Dec JBLU JetBlue $20.46 / -0.035 (-0.17%) 03/31/21 Delta Air Lines to begin selling all seats on flights starting May 1, CNBC says 03/29/21 CDC chief warns of 'impending doom' amid rise in travel, AP reports 03/18/21 Biden administration looks to ease travel restrictions in mid-May, CNBC says 03/18/21 Goldman in talks to take over JetBlue credit-card program, WSJ reports JBLU JetBlue $20.46 / -0.035 (-0.17%) 10:13 Today FedEx, Booking Holdings upgrades among today's top calls on Wall Street 04/05/21 Tesla upgrade, GM initiation among today's top calls on Wall Street 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 01/28/21 Fly Intel: Pre-market Movers 04/15/21 Aerospace & Defense 05/13/21 JetBlue Airways Corporation JBLU JetBlue $20.46 / -0.035 (-0.17%) 02/05/21 Unusual call flow in option market yesterday 02/04/21 JetBlue call volume above normal and directionally bullish 01/28/21 Unusually active option classes on open January 28th 01/13/21 JetBlue call volume above normal and directionally bullish
General news	FX Action: USD-JPY » 11:45 04/13/21 04/13 11:45 04/13/21 11:45 $ECON Economic Data / + FX Action: USD-JPY topped… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
General news	European Fixed Income Summary: » 11:45 04/13/21 04/13 11:45 04/13/21 11:45 $ECON Economic Data / + European Fixed Income… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
Conference/Events	Hawaiian Airlines executives participate in a virtual event » 11:45 04/13/21 04/13 11:45 04/13/21 11:45 HA Hawaiian Holdings $25.14 / -0.39 (-1.53%) Stanford Institute for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HA Hawaiian Holdings $25.14 / -0.39 (-1.53%) 03/17/21 Hawaiian Airlines launches Ontario-Honolulu service 01/26/21 Hawaiian Holdings sees FY21 Cap-Ex $50M-$70M 01/05/21 CEO says XpresSpa adding more airport, airlines on-site COVID test locations 10/27/20 Hawaiian Holdings sees Q4 capacity about 70% below Q419 HA Hawaiian Holdings $25.14 / -0.39 (-1.53%) 03/22/21 Stifel Hawaiian Holdings price target raised to $27 from $19 at Stifel 03/16/21 Goldman Sachs Hawaiian Holdings price target raised to $14 from $7 at Goldman Sachs 03/05/21 Wolfe Research Wolfe upgrades Hawaiian Holdings to Peer Perform on tourism 'snap up' potential 03/05/21 Wolfe Research Hawaiian Holdings upgraded to Peer Perform from Underperform at Wolfe Research HA Hawaiian Holdings $25.14 / -0.39 (-1.53%) 03/24/21 Hawaiian Holdings raises Q1 revenue view to down approximately 72%-74% y/y 01/26/21 Hawaiian Holdings reports Q4 EPS ($3.50), consensus ($3.53) 10/27/20 Hawaiian Holdings reports Q3 adjusted EPS ($3.76), consensus ($3.48) HA Hawaiian Holdings $25.14 / -0.39 (-1.53%) 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 11/09/20 Fly Intel: Wall Street's top stories for Monday 11/09/20 Fly Intel: Wall Street's top stories at midday 12:00 Today Hawaiian Airlines Executives Deliver Speech 05/19/21 Hawaiian Holdings Inc. HA Hawaiian Holdings $25.14 / -0.39 (-1.53%) 11/27/20 Unusual call flow in option market yesterday 11/25/20 Deep in the money calls see action in Hawaiian Airlines 11/18/20 Hawaiian Holdings put volume heavy and directionally bearish
Conference/Events	Federal Reserve Bank of Kansas City president participates in virtual event » 11:45 04/13/21 04/13 11:45 04/13/21 11:45 Kansas City Federal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Upgrade	Vaalco Energy upgraded to Buy from Neutral at Roth Capital » 11:44 04/13/21 04/13 11:44 04/13/21 11:44 EGY Vaalco Energy $2.20 / -0.04 (-1.79%) Roth Capital analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research EGY Vaalco Energy $2.20 / -0.04 (-1.79%) 04/12/21 Vaalco Energy CEO Cary Bounds to leave, George Maxwell to succeed 03/18/21 Vaalco Energy CFO Elizabeth Prochnow to retire 11/17/20 Vaalco Energy to acquire Sasol Gabon interest in Etame Marine block EGY Vaalco Energy $2.20 / -0.04 (-1.79%) 04/12/21 Roth Capital Vaalco Energy downgraded to Neutral from Buy at Roth Capital 03/24/21 Roth Capital Vaalco Energy initiated with a Buy at Roth Capital
Recommendations	Fortuna Silver Mines price target raised to C$12.50 from C$12.25 at BMO Capital » 11:43 04/13/21 04/13 11:43 04/13/21 11:43 FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) BMO Capital analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 04/12/21 Fortuna Silver Mines produces 1.9M ounces of silver, 34.555 ounces of gold in Q1 02/01/21 Silver producers up in pre-market on r/wallstreetbets short squeeze speculation 01/28/21 Fortuna Silver Mines rises 20.4% 01/19/21 Fortuna Silver Mines sees FY21 gold production 178,000-202,000 ounces FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 03/29/21 BMO Capital Fortuna Silver Mines price target lowered to $12.75 from $13 at BMO Capital 03/11/21 BMO Capital Fortuna Silver Mines price target raised to C$13 from C$12 at BMO Capital 02/08/21 CIBC Fortuna Silver Mines price target lowered to C$11.25 from C$11.50 at CIBC 02/02/21 National Bank Fortuna Silver Mines price target raised to C$13.50 from C$13 at National Bank FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 03/10/21 Fortuna Silver Mines reports Q4 EPS 10c, consensus 10c 11/13/20 Fortuna Silver Mines reports Q3 EPS 7c, consensus 10c FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 02/01/21 CME raises Silver futures margins by 18% to curb volatility, Bloomberg says FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 02/01/21 Fly Intel: Wall Street's top stories for Monday 02/01/21 Fly Intel: Wall Street's top stories at midday 11/13/20 Fly Intel: Pre-market Movers FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 02/01/21 Fortuna Silver Mines call volume above normal and directionally bullish 02/01/21 Unusually active option classes on open February 1st 01/28/21 Fortuna Silver Mines call volume above normal and directionally bullish 01/21/21 Fortuna Silver Mines call volume above normal and directionally bullish
Conference/Events	Global Ship Lease management to meet virtually with Jefferies » 11:42 04/13/21 04/13 11:42 04/13/21 11:42 GSL Global Ship Lease $12.75 / -0.14 (-1.09%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events GSL Global Ship Lease $12.75 / -0.14 (-1.09%) 04/09/21 Global Ship Lease falls -7.2% 02/09/21 Global Ship Lease to acquire seven Post-Panamax containerships for $116M 01/22/21 Global Ship Lease falls -12.5% 01/22/21 Global Ship Lease falls -12.4% GSL Global Ship Lease $12.75 / -0.14 (-1.09%) 02/12/21 Fly Intel: Top five analyst initiations 02/12/21 Jefferies Global Ship Lease initiated with a Buy at Jefferies 01/15/21 B. Riley Securities Global Ship Lease price target raised to $20 from $16 at B. Riley Securities 01/06/21 B. Riley Securities Global Ship Lease price target raised to $16 from $12 at B. Riley Securities GSL Global Ship Lease $12.75 / -0.14 (-1.09%) 03/04/21 Global Ship Lease reports Q4 revenue $70M, consensus $69.18M 09 Apr 22 Jan GSL Global Ship Lease $12.75 / -0.14 (-1.09%) 04/09/21 Fly Intel: Pre-market Movers 12:00 Today Global Ship Lease
Initiation	Daqo New Energy initiated with a Sell at GLJ Research » 11:39 04/13/21 04/13 11:39 04/13/21 11:39 DQ Daqo New Energy $66.50 / -0.54 (-0.81%) GLJ Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/16/21 Daqo New Energy enters three-year polysilicon supply agreement with Gaojing 03/09/21 Daqo New Energy rises 22.7% 03/09/21 Daqo New Energy rises 16.2% 03/09/21 Daqo New Energy rises 14.1% DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/10/21 Roth Capital Daqo New Energy price target lowered to $97 from $115 at Roth Capital 03/02/21 Roth Capital Daqo New Energy price target raised to $115 from $105 at Roth Capital 02/08/21 Roth Capital Bill could be 'meaningful positive' for solar stocks, says Roth Capital 01/26/21 Roth Capital Daqo New Energy price target raised to $100 from $40 at Roth Capital DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/09/21 Daqo New Energy reports Q4 EPS $1.07, one estimate $1.15 DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 01/08/21 JinkoSolar, Daqo named in report on companies tied to forced labor use, NYT says DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/09/21 Fly Intel: Pre-market Movers 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 04/22/21 Alternative Energy DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 02/25/21 Daqo New Energy call volume above normal and directionally bullish 01/11/21 Daqo New Energy put volume heavy and directionally bearish
Hot Stocks	MoneyGram announces partnership with Sigue Corporation » 11:34 04/13/21 04/13 11:34 04/13/21 11:34 MGI MoneyGram $6.46 / -0.01 (-0.15%) MoneyGram International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MGI MoneyGram $6.46 / -0.01 (-0.15%) 04/06/21 MoneyGram appoints Hilary Jackson as COO 03/24/21 MoneyGram announces launch of 'MoneyGram as a Service' business 03/18/21 MoneyGram to join Pay+ mobile wallet, expand in Middle East 03/11/21 MoneyGram's digital business reports 118% y-o-y transaction growth in February MGI MoneyGram $6.46 / -0.01 (-0.15%) 02/25/21 Barclays MoneyGram price target raised to $6 from $4.50 at Barclays 01/19/21 DA Davidson DA Davidson doesn't see Walmart adding Western Union to hurt Euronet materially 01/11/21 Northland MoneyGram upgraded to Outperform from Market Perform at Northland 08/03/20 Evercore ISI MoneyGram upgraded to In Line from Underperform at Evercore ISI MGI MoneyGram $6.46 / -0.01 (-0.15%) 02/22/21 MoneyGram sees Q1 revenue approximately $300M, consensus $298.53M 02/22/21 MoneyGram reports Q4 adjusted EPS 12c, consensus 8c 01/25/21 Fly Intel: What to watch in credit card space earnings reports 10/30/20 MoneyGram sees Q4 revenue growth of 1%, consensus $308.02M MGI MoneyGram $6.46 / -0.01 (-0.15%) 12/21/20 MoneyGram backs stronger due diligence rule, WSJ reports MGI MoneyGram $6.46 / -0.01 (-0.15%) 03/12/21 The Intersection: Crypto and Wall Street This Week 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers 05/05/21 MoneyGram International Inc MGI MoneyGram $6.46 / -0.01 (-0.15%) 12/16/20 MoneyGram call volume above normal and directionally bullish 12/03/20 MoneyGram call volume above normal and directionally bullish 11/20/20 MoneyGram call volume above normal and directionally bullish 11/16/20 MoneyGram call volume above normal and directionally bullish

Recommendations	Novocure price target raised to $215 from $135 at Wells Fargo » 11:34 04/13/21 04/13 11:34 04/13/21 11:34 NVCR Novocure $183.50 / +51.89 (+39.43%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NVCR Novocure $183.50 / +51.89 (+39.43%) 07:48 Today Zai Lab partner Novocure updates phase 3 Lunar trial in tumor fields in NSCLC 07:40 Today Novocure: DMC recommends continuation of LUNAR trial 12/14/20 Novocure announces BAG to add Optune combination to MiGeL 12/10/20 Novocure enrolls 1st patient in global phase 3 TRIDENT trial NVCR Novocure $183.50 / +51.89 (+39.43%) 10:48 Today Guggenheim Zai Lab price target raised to $250 from $165 at Guggenheim 09:26 Today Piper Sandler DMC review 'clear positive' for Novocure, says Piper Sandler 03/01/21 Mizuho Novocure price target raised to $175 from $150 at Mizuho 02/25/21 Piper Sandler 'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler NVCR Novocure $183.50 / +51.89 (+39.43%) 02/25/21 Novocure reports Q4 EPS 4c, consensus 12c 01/11/21 Novocure sees FY20 revenue $494.4M, consensus $482.29M 01/11/21 Novocure sees Q4 revenue $144M, consensus $133.26M 10/29/20 Novocure reports Q3 EPS 9c, consensus 3c NVCR Novocure $183.50 / +51.89 (+39.43%) 08:58 Today Fly Intel: Pre-market Movers 04/29/21 Novocure - NVCR
Periodicals	GM shortens expected downtime at Tennessee plant, CNBC reports » 11:28 04/13/21 04/13 11:28 04/13/21 11:28 GM General Motors $58.37 / -1.295 (-2.17%) General Motors is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 General Motors launches Maps+ in-vehicle navigation solution 04/06/21 GM says Chevrolet will introduce Silverado electric pickup truck 04/05/21 GM to reveal plans for additional EV production at Factory ZERO plant 04/01/21 GM targets recovering lost production where possible in second half GM General Motors $58.37 / -1.295 (-2.17%) 04/05/21 Fly Intel: Top five analyst initiations 04/05/21 Wells Fargo General Motors initiated with an Overweight at Wells Fargo 03/29/21 Jefferies General Motors price target raised to $62 from $50 at Jefferies 03/24/21 Morgan Stanley American Axle downgraded to Underweight on ICE phase out risk at Morgan Stanley GM General Motors $58.37 / -1.295 (-2.17%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 Chip shortage meeting not seen producing substantive outcomes, Bloomberg says 04/12/21 General Motors' Cruise to expand self-driving vehicles to Dubai, CNBC reports 04/09/21 GM to cut overtime production at two U.S. truck plants this weekend, CNBC says 04/08/21 GM to pause output at several North American plants amid chip shortage, WSJ says GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 Charged: White House proposal calling for $100B in new EV consumer rebates 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Charged: Wedbush says buy Tesla after 'paradigm changer' deliveries GM General Motors $58.37 / -1.295 (-2.17%) 04/07/21 Notable open interest changes for April 7th 03/24/21 General Motors call volume above normal and directionally bullish 03/03/21 Notable open interest changes for March 3rd 03/02/21 General Motors call volume above normal and directionally bullish
Options	iQiyi call volume above normal and directionally bullish » 11:25 04/13/21 04/13 11:25 04/13/21 11:25 IQ iQIYI $16.69 / +0.515 (+3.18%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options IQ iQIYI $16.69 / +0.515 (+3.18%) 03/31/21 Moonbug Entertainment brings CoComelon to China through iQIYI partnership 03/15/21 iQIYI, Clover Films announce collaboration for four upcoming film productions 02/10/21 iQIYI Launches Imax Enhanced in China 02/08/21 Aurora Mobile enters partnership agreement with iQIYI IQ iQIYI $16.69 / +0.515 (+3.18%) 02/22/21 KeyBanc iQIYI upgraded to Overweight from Sector Weight at KeyBanc 02/18/21 Fly Intel: Top five analyst downgrades 02/18/21 JPMorgan iQIYI downgraded to Underweight from Neutral at JPMorgan 01/19/21 UBS iQIYI downgraded to Neutral from Buy at UBS IQ iQIYI $16.69 / +0.515 (+3.18%) 02/17/21 iQIYI sees Q1 revenue $1.08B-$1.15B, consensus $1.13B 02/17/21 iQIYI reports Q4 EPS (32c), consensus (38c) 11/16/20 iQIYI sees Q4 revenue $1.07B-$1.14B, consensus $1.13B 11/16/20 iQIYI reports Q3 EPS (24c), consensus (40c) 17 Dec IQ iQIYI $16.69 / +0.515 (+3.18%) 03/29/21 Former Tiger Asia manager triggered $30B in stock sales, WSJ reports 12/02/20 House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says 11/27/20 Alibaba, Tencent put talks to buy control of iQIYI on hold, Reuters reports 10/13/20 Chinese online video platforms drop Apple iPhone event, Bloomberg's Yuan reports IQ iQIYI $16.69 / +0.515 (+3.18%) 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues 12/16/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: After-Hours Movers IQ iQIYI $16.69 / +0.515 (+3.18%) 04/07/21 Notable open interest changes for April 7th 04/06/21 iQiyi call volume above normal and directionally bullish 04/06/21 Unusually active option classes on open April 6th 03/25/21 iQiyi put volume heavy and directionally bearish
Conference/Events	Cowen Washington strategist to hold analyst/industry conference call » 11:25 04/13/21 04/13 11:25 04/13/21 11:25 Washington Strategist… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Periodicals	KKR planning to outbid CVC for Toshiba with offer in excess of $20B, FT reports » 11:23 04/13/21 04/13 11:23 04/13/21 11:23 TOSYY Toshiba $20.85 / +0.03 (+0.14%) , KKR KKR $52.09 / +0.08 (+0.15%) KKR (KKR) is planning to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/09/21 Toshiba chairperson Osamu Nagayama comments on CVC Capital acquisition proposal 04/06/21 Toshiba confirms acquisition proposal from CVC Capital 03/02/21 Farallon Capital urges Toshiba shareholders to support Farallon EGM proposal KKR KKR $52.09 / +0.08 (+0.15%) 04/08/21 KKR to lead purchase of $500M of convertible preferred stock in Box 04/08/21 Box reaffirms vision to deliver Content Cloud, drive profitable growth 04/08/21 Box announces partnership with KKR, including $500M KKR-led investment 04/08/21 Box announces partnership with KKR, including $500M KKR-led investment TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 03/19/21 SMBC Nikko Toshiba upgraded to Outperform from Neutral at SMBC Nikko 02/19/21 Citi Toshiba resumed with a Neutral at Citi 04/22/20 UBS Toshiba downgraded to Neutral from Buy at UBS KKR KKR $52.09 / +0.08 (+0.15%) 04/09/21 DA Davidson Box price target lowered to $22 from $25 at DA Davidson 04/09/21 William Blair KKR investment 'strong vote of confidence' in Box, says William Blair 04/09/21 William Blair KKR investment 'strong vote of confidence' in Box, says William Blair 04/07/21 Seaport Global Seaport downgrades Sempra Energy to Neutral after 'good, not great' SIP deal KKR KKR KKR $52.09 / +0.08 (+0.15%) 02/08/21 KKR reports Q4 EPS 49c, consensus 40c 02/08/21 Notable companies reporting after market close 10/30/20 KKR reports Q3 EPS 48c, consensus 40c 11 Nov TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/06/21 CVC to propose taking Toshiba private at 30% premium, Nikkei says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/18/20 Toshiba shareholder escalates dispute with management, FT reports 12/14/20 Toshiba, Fuji Electric to invest $1.9B in EV power chips, Nikkei reports KKR KKR $52.09 / +0.08 (+0.15%) 03/23/21 Thoma Bravo to acquire Calabrio from KKR, no terms, Reuters reports 03/17/21 Fly Leasing receives six bids for aircraft leasing portfolio, AFJ reports 03/11/21 KKR targets $12B for flagship global infrastructure fund, Reuters reports 02/19/21 Apple demands Steam sales data from Valve, PCGamer reports TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/06/21 Fly Intel: Wall Street's top stories for Tuesday KKR KKR $52.09 / +0.08 (+0.15%) 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Game On: Microsoft completes Bethesda deal, promises exclusive games 01/12/21 Game On: Roblox files for direct listing as GameStop adds new directors 08:30 Today KKR & Co. Inc.

Recommendations	Stelco Holdings price target raised to C$34 from C$29 at RBC Capital » 11:20 04/13/21 04/13 11:20 04/13/21 11:20 STZHF Stelco Holdings $23.05 / -0.23 (-0.99%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events STZHF Stelco Holdings $23.05 / -0.23 (-0.99%) 03/31/21 Scotiabank Stelco Holdings price target raised to C$32 from C$30 at Scotiabank 02/24/21 RBC Capital Stelco Holdings upgraded to Outperform from Sector Perform at RBC Capital 02/22/21 Exane BNP Paribas Stelco Holdings upgraded to Outperform from Neutral at Exane BNP Paribas 02/03/21 Credit Suisse Stelco Holdings upgraded to Outperform from Neutral at Credit Suisse 00:00 Today Scrap, Direct Reduced Iron & Mini-Mills 2021
General news	Treasury announced an $80 B set of 4- and 8-week bill auctions for Thursday » 11:20 04/13/21 04/13 11:20 04/13/21 11:20 $ECON Economic Data / + Treasury announced an $80… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Recommendations	Ascot Resources price target lowered to C$1.85 from C$2 at Desjardins » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 AOTVF Ascot Resources / + Desjardins analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research AOTVF Ascot Resources / + 03/18/21 Ascot Resources provides update on permitting, engineering of PGP 11/19/20 Ascot Resources announces high-grade gold intercepts at the Day Zone 10/15/20 Ascot Resources places order for SAG, ball mills AOTVF Ascot Resources / + 12/11/20 Raymond James Ascot Resources price target raised to C$2 from C$1.75 at Raymond James 09/25/20 Raymond James Ascot Resources initiated with a Strong Buy at Raymond James 04/29/20 Roth Capital Roth Capital bullish on Ascot Resources, initiates with a Buy 04/29/20 Roth Capital Ascot Resources initiated with a Buy at Roth Capital
Recommendations	Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) After Rigel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 07:07 Today Rigel announces results from Phase 2 clinical trial of fostamatinib 04/07/21 Rigel Pharmaceuticals closes R552 licensing agreement with Eli Lilly 03/11/21 Rigel Pharma completes patient enrollment for Phase 2 trial of fostamatinib 02/18/21 Eli Lilly, Rigel Pharmaceuticals enter exclusive license agreement for R552 RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 JPMorgan Rigel Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 03/02/21 Rigel Pharmaceuticals reports Q4 EPS (11c), consensus (11c) 01/11/21 Rigel Pharmaceuticals sees Q4 revenue approximately $18.4M, consensus $17.81M 11/05/20 Rigel Pharmaceuticals reports Q3 EPS (8c), consensus (12c) RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 01/15/21 Rigel looks to choke 'storm' that causes Covid patients to die, SFBT says 08:00 Today Rigel Pharmaceuticals - RIGL 05/18/21 Rigel Pharmaceuticals Inc.
Conference/Events	Immunocore participates in a conference call with JPMorgan » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 IMCR Immunocore $34.25 / +2.03 (+6.30%) SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/25/21 Immunocore expects cash to fund requirement through at least the end of 2022 02/19/21 Immunocore's tebentafusp granted Breakthrough Therapy Designation IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/02/21 Jefferies Immunocore initiated with a Buy at Jefferies 03/02/21 JPMorgan Immunocore initiated with an Overweight at JPMorgan 03/02/21 Goldman Sachs Immunocore initiated with a Neutral at Goldman Sachs IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/25/21 Immunocore reports 2020 EPS (GBP2.79) vs. (GBP4.66) last year 05 Feb IMCR Immunocore $34.25 / +2.03 (+6.30%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 07:30 Today Immunocore - IMCR 04/14/21 Immunocore - IMCR

Technical Analysis	NASDAQ market internals summary » 11:17 04/13/21 04/13 11:17 04/13/21 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 04/12/21 NASDAQ market internals summary 04/12/21 NASDAQ market internals summary 04/12/21 NASDAQ market internals summary
Conference/Events	Akero Therapeutics participates in a conference call with JPMorgan » 11:16 04/13/21 04/13 11:16 04/13/21 11:16 AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/23/21 Akero says1st patient randomized for dosing in EFX study in F2/F3 NASH patients 03/22/21 Akero Therapeutics histological improvements in cirrhotic NASH post cohort C 11/13/20 Akero announces presentation of additional BALANCED study data analysis 10/16/20 Akero Therapeutics receives EMA PRIME designation for efruxifermin in NASH AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/23/21 H.C. Wainwright Akero Therapeutics price target raised to $68 from $61 at H.C. Wainwright 03/23/21 Chardan Akero NASH data 'very exciting outcome,' says Chardan 03/17/21 Chardan Akero Therapeutics price target raised to $81 from $79 at Chardan 02/26/21 Guggenheim Akero Therapeutics initiated with a Buy at Guggenheim AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/16/21 Akero Therapeutics reports Q4 EPS (86c), consensus (59c) 11/12/20 Akero Therapeutics reports Q3 EPS (63c), consensus (65c) 08 Jul AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/16/21 Fly Intel: Pre-market Movers 13:00 Today Akero Therapeutics - AKRO
Technical Analysis	NYSE market internals summary » 11:16 04/13/21 04/13 11:16 04/13/21 11:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 04/12/21 NYSE market internals summary 04/12/21 NYSE market internals summary 04/12/21 NYSE market internals summary
Recommendations	Western Forest price target raised to C$2.50 from C$1.90 at CIBC » 11:15 04/13/21 04/13 11:15 04/13/21 11:15 WFSTF Western Forest $1.59 / -0.0029 (-0.18%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WFSTF Western Forest $1.59 / -0.0029 (-0.18%) 03/03/21 Scotiabank Western Forest price target raised to C$2.25 from C$2 at Scotiabank 02/22/21 RBC Capital Western Forest price target raised to C$2 from C$1.50 at RBC Capital 02/22/21 TD Securities Western Forest price target raised to C$2 from C$1.75 at TD Securities 02/19/21 Scotiabank Western Forest price target raised to C$2 from C$1.50 at Scotiabank
Recommendations	West Fraser Timber price target raised to C$135 from C$120 at CIBC » 11:15 04/13/21 04/13 11:15 04/13/21 11:15 WFG West Fraser Timber $82.77 / +0.95 (+1.16%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research WFG West Fraser Timber $82.77 / +0.95 (+1.16%) 04/07/21 Scotiabank West Fraser Timber price target raised to C$120 from C$106 at Scotiabank 03/26/21 TD Securities West Fraser Timber upgraded to Action List Buy from Buy at TD Securities 03/03/21 Scotiabank West Fraser Timber price target raised to C$106 from C$103 at Scotiabank 02/16/21 TD Securities West Fraser Timber price target raised to $91 from $86 at TD Securities

Events

Earnings calls, analyst events, roadshows and more

HA
Today at 12:00

Hawaiian Airlines Executives Deliver Speech Government Event

Virtual Event
Today at 12:00

Fed Reserve Bank President Speaks on Economic Conditions Government Event

Virtual Event
Today at 12:00

Fed Reserve Bank President Delivers Opening Remarks Government Event

Virtual Event
GSL
Today at 12:00

Global Ship Lease Firm Sponsored Meetings

Virtual Meeting
Today at 12:00

Washington Research Policy Industry Meetings
Today at 12:00

Biotech/Pharma Industry Meetings
Today at 13:00

30-Year Bond Auction Government Event
AKRO
Today at 13:00

Akero Therapeutics - AKRO Conference Calls
Today at 13:15

Fed Reserve Bank President Moderates Virtual Panel Government Event

Virtual Event
BKSC
Today at 14:00

Bank of South Carolina Corp Firm Sponsored Meetings

256 Meeting St, Charleston, SC

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $ 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

AbbVie announces extension of review of sNDA of upadacitinib

TODAY'S FREE FLY STORIES

Get Full Fly Access